The 150 most important questions in cancer research and clinical oncology series: questions 102–104
Visualized Cancer Medicine · 2024
DOI: 10.1051/vcm/2024005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Visualized Cancer Medicine, 2024. Verfasst von Zhimin Lu. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To accelerate our endeavors to overcome cancer, Visualized Cancer Medicine continues the previously launched program of publishing the 150 most important questions in cancer research and clinical oncology. In this article, three more questions are presented as follows: Question 102: Can non-glucose-based tumor imaging techniques facilitate tumor detection and metabolic classification? Question 103: how can we develop medicines to inhibit the cancer-specific metabolic functions of metabolic enzymes in tumors expressing wild-type IDH, without interfering with their canonical catalytic activities? Question 104: Can dietary-based cancer therapy be proven effective in treating cancer?
Zitieren
APA
Lu, Z. (2024). The 150 most important questions in cancer research and clinical oncology series: questions 102–104. Visualized Cancer Medicine. https://doi.org/10.1051/vcm/2024005
Vancouver
Lu Z. The 150 most important questions in cancer research and clinical oncology series: questions 102–104. Visualized Cancer Medicine. 2024. doi:10.1051/vcm/2024005
BibTeX
@article{Lu2024,
author = {Lu, Zhimin},
title = {The 150 most important questions in cancer research and clinical oncology series: questions 102–104},
journal = {Visualized Cancer Medicine},
year = {2024},
doi = {10.1051/vcm/2024005}
}
EUVIMED